Renal Cancer - Results from #2020

Three-dimensional Coculture Provides an Improved in Vitro Model for Papillary Renal Cell Carcinoma. May 28, 2021

Propofol inhibits the proliferation, migration, invasion and epithelial to mesenchymal transition of renal cell carcinoma cells by regulating microRNA-363/Snail1. May 28, 2021

Combining Stereotactic Body Radiotherapy and Microwave Ablation Appears Safe and Feasible for Renal Cell Carcinoma in an Early Series. May 27, 2021

Leibovich score is the optimal clinico-pathological system associated with recurrence of non-metastatic clear cell renal cell carcinoma. May 27, 2021

Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib. May 26, 2021

NUPR1 is a novel potential biomarker and confers resistance to sorafenib in clear cell renal cell carcinoma by increasing stemness and targeting the PTEN/AKT/mTOR pathway. May 26, 2021

Comparison of PD-L1 Scores in Primary Kidney Tumors Versus Accompanying Venous Tumor Thrombi: Retrospective, Comparative, Monocentric Study in Treatment-Naive Patients. May 25, 2021

Improving Renal Tumor Biopsy Prognostication With BAP1 Analyses. May 25, 2021

Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages. May 25, 2021

Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data. May 24, 2021

Retroperitoneal Robot-Assisted Partial Nephrectomy (rRAPN): Surgical Technique and Review. May 24, 2021

Detection of von Hippel-Lindau gene mutation in circulating cell-free DNA for clear cell renal cell carcinoma. May 21, 2021

A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma. May 21, 2021

Autonomous pick-and-place using the dVRK. May 20, 2021

Clear Cell Renal Carcinoma: MicroRNAs With Efficacy in Preclinical In Vivo Models. May 20, 2021

Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma. May 19, 2021

Q-TWiST Analysis of Tivozanib Versus Sorafenib in Patients With Advanced Renal Cell Carcinoma in the TIVO-3 Study. May 19, 2021

Response to systemic therapy in fumarate hydratase-deficient renal cell carcinoma. May 18, 2021

Functional inhibition of cancer stemness-related protein DPP4 rescues tyrosine kinase inhibitor resistance in renal cell carcinoma. May 18, 2021

TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study. May 17, 2021

Page 102 of 456